These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9711355)

  • 21. Mecillinam resistance in Escherichia coli is conferred by loss of a second activity of the AroK protein.
    Vinella D; Gagny B; Joseleau-Petit D; D'Ari R; Cashel M
    J Bacteriol; 1996 Jul; 178(13):3818-28. PubMed ID: 8682786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the ftsA1p promoter in the resistance of mucoid mutants of Salmonella enterica to mecillinam: characterization of a new type of mucoid mutant.
    Costa CS; Antón DN
    FEMS Microbiol Lett; 2001 Jun; 200(2):201-5. PubMed ID: 11425476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory studies on mecillinam: activity alone and combined with cephradine.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():53-8. PubMed ID: 587708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter.
    Fuglesang JE; Bergan T; Bielecki T; Naterstad A; Namork E
    Infection; 1981; 9(6):290-5. PubMed ID: 6277795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the antibacterial activity of a number of new antibiotics and their combinations in relation to Pseudomonas aeruginosa].
    Bekbergenov BM; Moroz AF; Rudzit EA; Stepanets TH
    Antibiotiki; 1979 May; 24(5):340-3. PubMed ID: 109038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mecillinam has potent in vitro activity against Chlamydophila pneumoniae ATCC VR1310.
    Bostock JM; Geary I; Eley A; Chopra I
    J Antimicrob Chemother; 2004 Jun; 53(6):1112. PubMed ID: 15166212
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
    Stille W; Bischof-Léger E; Helm EB
    Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mecillinam on Escherichia coli growth curves when given alone and associated with ampicillin.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Scand J Infect Dis; 1986; 18(5):439-45. PubMed ID: 3535050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased susceptibility of Serratia marcescens to chlorhexidine related to the inner membrane.
    Lannigan R; Bryan LE
    J Antimicrob Chemother; 1985 May; 15(5):559-65. PubMed ID: 3891711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of in vitro and in vivo ampicillin susceptibility of Escherichia coli pretreated with low concentrations of mecillinam and ampicillin.
    van der Voet GB; Mattie H; van Furth R
    Scand J Infect Dis; 1983; 15(1):97-101. PubMed ID: 6302833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.
    Perea EJ; Palomares JC; García-Iglesias MC
    Chemotherapy; 1980; 26(4):282-8. PubMed ID: 6248300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buoyant density studies of several mecillinam-resistant and division mutants of Escherichia coli.
    Bylund JE; Haines MA; Walsh K; Bouloc P; D'Ari R; Higgins ML
    J Bacteriol; 1991 Sep; 173(17):5396-402. PubMed ID: 1885519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens.
    Farrar WE; O'dell NM
    J Infect Dis; 1976 Sep; 134(3):245-51. PubMed ID: 789784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of mecillinam and mecillinam/ampicillin combinations on Proteus species.
    Hone R; Foley M
    J Antimicrob Chemother; 1980 May; 6(3):410-2. PubMed ID: 6249783
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta-lactamine associations. In vitro synergism and clinical results].
    Acar JF
    Pathol Biol (Paris); 1971; 19(11):593-7. PubMed ID: 4997292
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cephapirin and mecillinam on the phagocytic and respiratory burst activity of neutrophil leukocytes isolated from bovine blood.
    Dosogne H; Hoeben D; Burvenich C; Lohuis JA
    J Vet Pharmacol Ther; 1998 Dec; 21(6):421-7. PubMed ID: 9885963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.